Posts in tag

COVID-19


More than two years into the pandemic, we want to know how many of our pharmacist readers have contracted the virus, and how it may have affected your workplace… Life …

Debbie Rigby takes a look at the latest in research news Risk of first ischaemic stroke and use of antidopaminergic antiemetics Using French reimbursement data, researchers have shown an association …

Pharmacists in South Australia will now be able to immunise a wider range of people, the new Health Minister has announced Late last week South Australian Minister for Health and …

Community pharmacies across Australia reached another milestone with the seven millionth COVID-19 vaccine being administered by a community pharmacist on Friday National President of the Pharmacy Guild, Professor Trent Twomey, …

Coloradans told to re-vaccinate after pharmacy suspended from program; Well Pharmacy refutes coerced work claim; 10-year sentence for pharmacist’s role in US$180m fraud Denver, Colorado: A pharmacy has been suspended …

Angelo Pricolo muses on the strangeness of the pandemic’s most visible sign: the face mask When I think of masquerade I imagine an exotic ball with costumed revellers, some wearing …

Debbie Rigby rounds up the latest in research news Inhaled corticosteroids: not just for asthma, but for COVID-19? Inhaled budesonide might be beneficial in some cases of early COVID-19 when …

Local reactions, chest pain, vomiting, fever and headache were some of the most common adverse reactions reported in kids aged 5-11 for the Pfizer vaccine The TGA has received about …

The number of antibiotics prescribed in Australia fell by up to 38% during the COVID-19 pandemic, according to Monash Health researchers Their research, presented at this year’s European Congress of …

A pharmacist’s “vaccine hesitant” views have been heard in her quest to gain an exemption from the vaccine mandate The Queensland Industrial Relations Commission heard that the pharmacist was working …

Debbie Rigby takes a look at the latest in research news Oral antivirals for mild–moderate COVID‑19: a panacea or a logistical and clinical conundrum? Multiple therapeutic options for COVID-19 are …

Pfizer’s Comirnaty has been provisionally approved as a booster shot for 12 to 15 year olds But the Australian Technical Advisory Group on Immunisation says it does not currently recommend …